Riskpilot← Back to searchSign inGet full accessCURIDA AS
ASActiveOrg 815146352Solbærvegen 5, 2409 ElverumManufacture of pharmaceutical preparations · NACE 2120Est. 2015133 employees
Revenue 2024
NOK 279,8M
+13% vs 2023
EBITDA margin
5.8%
+201% vs 2023
Equity ratio
12.0%
Financial strength
Net profit 2024
NOK -13,4M
+65% vs 2023
| Revenue | NOK 279,8M | +13% |
| EBITDA | NOK 16,3M | +201% |
| Net profit | NOK -13,4M | +65% |
| Total assets | NOK 217,2M | +6% |
| Equity | NOK 26,1M | -34% |
| Employees | 133 | — |
Legal name
CURIDA AS
Org number
815146352
Legal form
Aksjeselskap
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
20. mars 2015
Share capital
NOK 15 015 000
Employees
133 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder alene. Styrets leder alene.
Company purpose
Etablere, utvikle og drive næringsvirksomhet med utgangspunkt i tilgjengelig kompetanse og anlegg på strandmoen i elverum, herunder å delta i andre selskaper med lignende virksomhet, kjøp og salg av aksjer, eller på annen måte gjøre seg interessert i andre foretagender. Primært vil selskapet engasjere seg i virksomhet innen produksjon av legemidler, medisinsk utstyr og kosttilskudd.
Address
Solbærvegen 5, 2409 Elverum
Phone
+4762428300
Email
post@curida.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11 151 | 50 018 | 46 549 | 45 229 | 73 338 | 111 524 | 134 443 | 198 122 | 248 393 | 279 751 |
| Staff expenses | −13 156 | −34 421 | −31 611 | −41 523 | −54 160 | −62 828 | −74 340 | −98 748 | −97 794 | −96 849 |
| EBITDA | −6 332 | −8 189 | −11 509 | −26 959 | −31 316 | −22 681 | −3 809 | −5 266 | 5 437 | 16 349 |
| Depreciation & amort. | −83 | −233 | −579 | −405 | −2 245 | −5 464 | −5 504 | −26 750 | −19 177 | −13 223 |
| EBIT | −6 415 | −8 422 | −12 088 | −27 364 | −33 561 | −28 145 | −9 313 | −32 016 | −13 740 | 3 126 |
| Net financials | −50 | −451 | −587 | −1 024 | −3 076 | −8 187 | −9 119 | −15 048 | −25 661 | −16 914 |
| Profit before tax | −6 465 | −8 873 | −12 675 | −28 388 | −36 637 | −36 332 | −18 432 | −47 064 | −39 401 | −13 788 |
| Tax | −1 619 | −2 042 | −2 754 | −165 | −970 | −2 544 | −2 449 | −1 316 | −1 279 | −398 |
| Net profit | −4 846 | −6 831 | −9 921 | −28 223 | −35 667 | −33 788 | −15 983 | −45 748 | −38 122 | −13 390 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 16 616 | 21 930 | 32 413 | 47 447 | 99 021 | 235 782 | 175 872 | 209 034 | 204 773 | 217 241 |
| Equity | 10 248 | 11 524 | 12 862 | −14 810 | −47 040 | 32 634 | 25 335 | 21 438 | 39 473 | 26 083 |
| Long-term debt | 0 | 0 | 287 | 37 | 10 000 | 19 950 | 19 394 | 8 333 | 620 | 0 |
| Short-term debt | 6 369 | 10 407 | 19 265 | 62 219 | 136 060 | 183 198 | 131 142 | 179 263 | 164 681 | 191 158 |
| Total debt | 6 369 | 10 407 | 19 551 | 62 256 | 146 060 | 203 148 | 150 536 | 187 596 | 165 301 | 191 158 |
EBITDA margin
5.8%
This company
15.8%
Market median
-63% vs market
20152024
Equity ratio
12.0%
This company
38.2%
Market median
-69% vs market
20152024
Return on equity
-51.3%
This company
18.4%
Market median
-379% vs market
20152024
Net profit margin
-4.8%
This company
8.1%
Market median
-159% vs market
20152024
Asset turnover
1.29×
This company
1.12×
Market median
+15% vs market
20152024
Debt / equity
7.33×
This company
0.62×
Market median
-1082% vs market
20152024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-03-11 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AP Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
LR Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Curida Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Curida Holding As
CURIDA AS Board members of CURIDA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Per Erik Larsson | Chief Executive Officer | 0 companies |
| Leif Rune Skymoen | Chief Executive Officer | 0 companies |
| Lars Tore Ramsberg | Board of Directors | 0 companies |
| Ole Jesper Dahlberg | Chairman | 0 companies |
| Terje Gabrielsen | Board of Directors | 0 companies |
| Anita Standal | Board of Directors | 0 companies |
| Per-Sveno Thoresen | Chairman | 0 companies |
| Øyvind Kongstun Arnesen | Board of Directors | 0 companies |